BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37347112)

  • 1. Predicting morphological and functional variations of benign adrenal incidentalomas in relation to initial characteristics.
    Parazzoli C; Favero V; Aresta C; Morelli V
    Front Endocrinol (Lausanne); 2023; 14():1179817. PubMed ID: 37347112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
    Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study.
    Ceccato F; Tizianel I; Voltan G; Maggetto G; Merante Boschin I; Quaia E; Crimì F; Scaroni C
    Front Endocrinol (Lausanne); 2021; 12():794197. PubMed ID: 34925247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
    Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
    Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Investigation of Adrenal Incidentalomas in Japanese Patients of the Fukuoka Region with Updated Diagnostic Criteria for Sub-clinical Cushing's Syndrome.
    Abe I; Sugimoto K; Miyajima T; Ide T; Minezaki M; Takeshita K; Takahara S; Nakagawa M; Fujimura Y; Kudo T; Miyajima S; Taira H; Ohe K; Ishii T; Yanase T; Kobayashi K
    Intern Med; 2018 Sep; 57(17):2467-2472. PubMed ID: 29709936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Apr; 64(1):1-13. PubMed ID: 30847651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
    Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
    Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study.
    Falcetta P; Orsolini F; Benelli E; Agretti P; Vitti P; Di Cosmo C; Tonacchera M
    Endocrine; 2021 Jan; 71(1):178-188. PubMed ID: 32915435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between adrenal adenoma size, autonomous cortisol secretion and metabolic derangements.
    Bleier J; Pickovsky J; Apter S; Fishman B; Dotan Z; Tirosh A; Shlomai G
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):311-318. PubMed ID: 34877671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
    Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year follow up of adrenal incidentalomas in a New Zealand centre.
    Goh Z; Phillips I; Hunt PJ; Soule S; Cawood TJ
    Intern Med J; 2020 Mar; 50(3):350-356. PubMed ID: 31058434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenal incidentaloma - differential diagnosis and management].
    Remde H; Kimpel O; Fassnacht M
    Dtsch Med Wochenschr; 2022 Jan; 147(3):85-91. PubMed ID: 35100640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
    Podbregar A; Janez A; Goricar K; Jensterle M
    BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic Variants of
    Mariani BMP; Nishi MY; Wanichi IQ; Brondani VB; Lacombe AMF; Charchar H; Pereira MAA; Srougi V; Tanno FY; Ceccato F; Regazzo D; Barbot M; Occhi G; Albiger NME; Vieira-Corrêa M; Kater CE; Scaroni C; Chambô JL; Zerbini MCN; Mendonca BB; Almeida MQ; Fragoso MCBV
    Front Endocrinol (Lausanne); 2020; 11():36. PubMed ID: 32117062
    [No Abstract]   [Full Text] [Related]  

  • 18. Adrenal incidentalomas showing unilateral concordant visualization by adrenocortical scintigraphy: comparison with adenomas in Cushing's syndrome.
    Tani A; Nakajo M; Tsuchimochi S; Nakabeppu Y; Umanodan T
    Ann Nucl Med; 2000 Jun; 14(3):205-12. PubMed ID: 10921486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Follow-Up Results of Adrenal Incidentaloma.
    Yilmaz N; Avsar E; Tazegul G; Sari R; Altunbas H; Balci MK
    Exp Clin Endocrinol Diabetes; 2021 May; 129(5):349-356. PubMed ID: 31958848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
    Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.